OBMPD Projected Dividend Yield
OncBioMune Pharmaceuticals Inc ( OTCBB : OBMPD )OncBioMune Pharmaceuticals is a biotechnology company focusing on cancer treatment therapies. Co. has proprietary rights to a breast and prostate patent vaccine, as well as a process for the growth of cancer tumors. Co.'s product portfolio consists of three target therapies and a vaccine platform that allows it to create a therapeutic vaccine for any solid tumor cancer. Co. is in the planning stage of a Phase 2 clinical trial of its key product, ProscaVax®. Co. is also focused on the development of its other proprietary technologies, such as the paclitaxel-albumin conjugate. 20 YEAR PERFORMANCE RESULTS |
OBMPD Dividend History Detail OBMPD Dividend News OBMPD Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |